Register for this Live Webinar
As oncology drug development accelerates, sponsors face a growing challenge: how to design clinical trials that keep pace with scientific innovation while remaining operationally feasible and patient-centred. This expert panel brings together leaders in first-in-human oncology, neuro-oncology, and global clinical strategy to examine the evolving landscape of trial design for emerging therapies, including cell and gene therapy, ADCs, bispecifics, and next-generation immunotherapies.
Audience will learn:
- Practical considerations for dose escalation, toxicity management, endpoint selection, and patient eligibility
- How to identify where traditional frameworks still apply and where innovative approaches are needed
- Strategies for balancing scientific ambition with operational realities
- Insights to position studies for meaningful clinical outcomes and efficient progression to later-phase development
Offered Free by: Worldwide Clinical Trials
See All Resources from: Worldwide Clinical Trials
